Short Term Sirolimus Treatment and MRI of the Brain and Lungs

PHASE1RecruitingINTERVENTIONAL

Enrollment

205

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Genetic Predisposition to DiseaseHealthy Volunteers

Interventions

DRUG

Sirolimus

1 mg of Sirolimus taken orally once a day for 4 weeks.

Trial Locations (1)

RECRUITING

University of Missouri-Columbia, Columbia

All Listed Sponsors

lead

University of Missouri-Columbia

OTHER